ClinicalTrials.gg
CompletedNCT07545330Updated Oct 1, 2026

Effect of Circadian Timing of a Standardized Meal on Postprandial Glucose Response in Healthy Adults

An interventional study of Standardized Test Meal in Meal Timing, Postprandial Glucose and Glycemic Response to Feeding in Healthy Participants, sponsored by King Faisal University. Completed at 1 site in Saudi Arabia. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-10-01.

Sponsored by King Faisal University · Not applicable, Interventional, and Basic science

Updated Oct 1, 2026Now CompletedStart date moved+3 moreGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
30
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

This randomized crossover study aims to investigate the effect of circadian timing of a standardized meal (morning versus evening consumption) on postprandial glucose response in healthy adults. Postprandial glucose will be assessed using the incremental area under the curve (iAUC) over 120 minutes.

02

Conditions studied

  • Meal Timing
  • Postprandial Glucose
  • Glycemic Response to Feeding in Healthy Participants
03

In context

Lead sponsor

King Faisal University is the lead sponsor of 15 studies on the registry; 2 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Healthy adults aged 18 years and older
  • Able and willing to provide
  • Able to comply with study procedures

Exclusion criteria

Exclusion Criteria:

  • Diagnosis of diabetes or any metabolic disorder affecting glucose regulation
  • Use of any medications
  • Pregnant or breastfeeding women
  • Night shift workers or individuals with irregular sleep patterns
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Randomized
Intervention model
Crossover assignment
Masking
None (open label)
Enrollment
30 participants (actual)

Study arms

  • Experimental
    Morning Meal Condition

    Participants will consume a standardized test meal in the morning following an overnight fasting period of at least 8 hours. Postprandial glucose will be measured over 120 minutes.

    Other: Standardized Test Meal

  • Experimental
    Evening Meal Condition

    Participants will consume the same standardized test meal in the evening following a standardized fasting period of at least 8 hours prior to the test meal. Postprandial glucose will be measured over 120 minutes.

    Other: Standardized Test Meal

Interventions

  • OtherStandardized Test Meal

    The standardized test meal provided 50 g of carbohydrates of weighed portions of white bread and jam, served with 200 mL of water.

06

What researchers measure

Primary outcomes

  1. Incremental Area Under the Curve (iAUC) for Postprandial Glucose

    The primary objective of this study is to investigate the effect of circadian timing of a standardized test meal (morning versus evening consumption) on postprandial glucose response in healthy adults, assessed as the incremental area under the curve (iAUC) for capillary blood glucose over 120 minutes following meal consumption

    Time frame: Baseline to 120 minutes after consumption of the standardized test meal

Secondary outcomes

  1. Peak Postprandial Glucose (Morning vs Evening)

    Peak capillary blood glucose concentration measured within 120 minutes after consumption of the standardized test meal, under morning and evening conditions

    Time frame: Baseline to 120 minutes after consumption of the standardized test meal

  2. Time to Peak Glucose (Morning vs Evening)

    Time required to reach peak capillary blood glucose concentration following meal consumption, under morning and evening conditions.

    Time frame: Baseline to 120 minutes after consumption of the standardized test meal

  3. Postprandial Glucose Profile (Morning vs Evening)

    Capillary blood glucose concentrations measured at predefined time points following consumption of the standardized test meal, under morning and evening conditions.

    Time frame: Baseline, 15, 30, 60, 90, and 120 minutes after consumption of the standardized test meal

Other outcomes

  1. Night Eating Behavior

    Night eating behavior will be assessed using the validated Night Eating Questionnaire to characterize nocturnal eating patterns and support interpretation of variability in postprandial glucose responses.

    Time frame: Baseline

  2. Sleep Duration and Quality

    Sleep duration and quality will be assessed using a validated sleep questionnaire administered prior to each study visit to support interpretation of postprandial glucose responses.

    Time frame: Baseline

  3. Chronotype

    Chronotype will be assessed at baseline using the validated Questionnaire to characterize individual circadian preference and support interpretation of postprandial glucose responses.

    Time frame: Baseline

07

Study locations

1 site
  • King Faisal University
    Al-Ahsa, Eastern Province 31982, Saudi Arabia
08

References and documents

Individual participant data

Plan to share: No — De-identified individual participant data (IPD) collected in this study will not be made publicly available. Data will be used for research purposes by the study investigators only

No publications or documents are linked to this record.

09

Updates

1 registry update since Sep 25, 2026
Status
Not yet recruiting→Completed
changed Oct 1, 2026
Start date
Apr 15, 2026→Apr 21, 2026 (actual)
Oct 1, 2026
Primary completion
May 30, 2026→Jul 15, 2026 (actual)
Oct 1, 2026
Study completion
May 30, 2026→Jul 15, 2026 (actual)
Oct 1, 2026
Enrollment
32 (estimated)→30 (actual)
Oct 1, 2026
Show all 1 update
  1. Oct 1, 2026
    Not yet recruiting→Completed
    Start date Apr 15, 2026→Apr 21, 2026 (now actual)
    Primary completion May 30, 2026→Jul 15, 2026 (now actual)
    Study completion May 30, 2026→Jul 15, 2026 (now actual)
    Enrollment 32 (estimated)→30 (actual)
    + 2 other changes: verification date and contact details

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07545330
Lead sponsor
King Faisal University
Collaborators
Saudi Food and Drug Authority
Responsible party
Sponsor
First posted
Apr 22, 2026
Start date
Apr 21, 2026
Primary completion
Jul 15, 2026
Completion
Jul 15, 2026
Last update
Oct 1, 2026

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion